ZA90600B - Treatment of leukocyte dysefunction with gm-csf - Google Patents

Treatment of leukocyte dysefunction with gm-csf

Info

Publication number
ZA90600B
ZA90600B ZA90600A ZA90600A ZA90600B ZA 90600 B ZA90600 B ZA 90600B ZA 90600 A ZA90600 A ZA 90600A ZA 90600 A ZA90600 A ZA 90600A ZA 90600 B ZA90600 B ZA 90600B
Authority
ZA
South Africa
Prior art keywords
csf
leukocyte
dysfunction
treating
dysefunction
Prior art date
Application number
ZA90600A
Other languages
English (en)
Inventor
Eric M Bonnem
M Bonnem Eric
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of ZA90600B publication Critical patent/ZA90600B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/193—Colony stimulating factors [CSF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • External Artificial Organs (AREA)
ZA90600A 1989-01-30 1990-01-26 Treatment of leukocyte dysefunction with gm-csf ZA90600B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US30439189A 1989-01-30 1989-01-30

Publications (1)

Publication Number Publication Date
ZA90600B true ZA90600B (en) 1990-10-31

Family

ID=23176323

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA90600A ZA90600B (en) 1989-01-30 1990-01-26 Treatment of leukocyte dysefunction with gm-csf

Country Status (21)

Country Link
US (1) US5178855A (fr)
EP (2) EP0382381B1 (fr)
JP (1) JPH0651640B2 (fr)
KR (1) KR0137361B1 (fr)
AT (1) ATE89737T1 (fr)
AU (1) AU633054B2 (fr)
CA (1) CA2045605C (fr)
DE (1) DE69001686T2 (fr)
DK (1) DK0382381T3 (fr)
ES (1) ES2055314T3 (fr)
FI (1) FI913625A0 (fr)
HK (1) HK46196A (fr)
HU (1) HU207229B (fr)
IE (1) IE64234B1 (fr)
IL (1) IL93219A (fr)
MY (1) MY105798A (fr)
NZ (1) NZ243953A (fr)
OA (1) OA09509A (fr)
PT (1) PT92995B (fr)
WO (1) WO1990008554A1 (fr)
ZA (1) ZA90600B (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0526630A4 (en) * 1991-02-22 1993-08-11 Amgen Inc. Use of gm-csf and g-csf to promote accelerated wound healing
GB9120304D0 (en) * 1991-09-24 1991-11-06 Erba Carlo Spa Stable pharmaceutical compositions containing a granulocyte macrophage colony stimulating factor
EP0661057A4 (fr) * 1993-06-08 1997-09-03 Ajinomoto Kk Accelerateur de la proliferation des cellules hematopietiques.
EP0791061A4 (fr) * 1994-03-04 1998-07-15 Ludwig Inst Cancer Res Animaux a rupture genique ciblee
US5942253A (en) 1995-10-12 1999-08-24 Immunex Corporation Prolonged release of GM-CSF
US6753165B1 (en) * 1999-01-14 2004-06-22 Bolder Biotechnology, Inc. Methods for making proteins containing free cysteine residues
US20080076706A1 (en) 1997-07-14 2008-03-27 Bolder Biotechnology, Inc. Derivatives of Growth Hormone and Related Proteins, and Methods of Use Thereof
US7153943B2 (en) * 1997-07-14 2006-12-26 Bolder Biotechnology, Inc. Derivatives of growth hormone and related proteins, and methods of use thereof
US8288126B2 (en) 1999-01-14 2012-10-16 Bolder Biotechnology, Inc. Methods for making proteins containing free cysteine residues
US6911204B2 (en) 2000-08-11 2005-06-28 Favrille, Inc. Method and composition for altering a B cell mediated pathology
US20080171089A1 (en) * 2006-12-22 2008-07-17 Blondino Frank E Stable anti-nausea oral spray formulations and methods
US7697268B2 (en) * 2007-08-09 2010-04-13 Haworth, Inc. Modular electrical distribution system for a building

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5078996A (en) * 1985-08-16 1992-01-07 Immunex Corporation Activation of macrophage tumoricidal activity by granulocyte-macrophage colony stimulating factor
WO1987002060A1 (fr) * 1985-10-03 1987-04-09 Biogen N.V. Polypeptides semblables aux facteurs de stimulation de colonies de granulocytes-macrophages (gm-csf) et leurs procedes de production en quantites importantes dans des cellules microbiennes
JPH0618778B2 (ja) * 1985-10-04 1994-03-16 中外製薬株式会社 白血球減少症治療剤
WO1987003204A1 (fr) * 1985-11-27 1987-06-04 Genetics Institute, Inc. Traitement de maladies du type du sida
WO1987006954A1 (fr) * 1986-05-06 1987-11-19 Genetics Institute, Inc. Production de m-csf
US5162111A (en) * 1986-07-30 1992-11-10 Grabstein Kenneth H Treatment of bacterial diseases with granulocyte-macrophage colony stimulating factor
EP0276846A3 (fr) * 1987-01-29 1989-07-26 Zymogenetics, Inc. Dérivés du facteur stimulant des colonies
EP0386109A1 (fr) * 1987-11-12 1990-09-12 Schering Corporation Acceleration de formation osseuse a l'aide de gm-csf

Also Published As

Publication number Publication date
HK46196A (en) 1996-03-22
ATE89737T1 (de) 1993-06-15
KR910700069A (ko) 1991-03-13
JPH0651640B2 (ja) 1994-07-06
NZ243953A (en) 1997-06-24
EP0382381B1 (fr) 1993-05-26
HUT57607A (en) 1991-12-30
KR0137361B1 (ko) 1998-04-25
DE69001686D1 (de) 1993-07-01
FI913625A0 (fi) 1991-07-30
DK0382381T3 (da) 1993-07-12
IE900318L (en) 1990-07-30
AU633054B2 (en) 1993-01-21
IL93219A0 (en) 1990-11-05
HU207229B (en) 1993-03-29
EP0455726A1 (fr) 1991-11-13
DE69001686T2 (de) 1993-09-02
CA2045605C (fr) 1997-02-11
JPH03504980A (ja) 1991-10-31
WO1990008554A1 (fr) 1990-08-09
PT92995A (pt) 1990-07-31
MY105798A (en) 1995-01-30
IE64234B1 (en) 1995-07-26
US5178855A (en) 1993-01-12
IL93219A (en) 1998-12-27
OA09509A (en) 1992-11-15
CA2045605A1 (fr) 1990-07-31
AU5048890A (en) 1990-08-24
ES2055314T3 (es) 1994-08-16
PT92995B (pt) 1995-12-29
EP0382381A1 (fr) 1990-08-16

Similar Documents

Publication Publication Date Title
TW265265B (fr)
HUT63564A (en) Medical preparatives, method for producing them and their applications as analgetic and/or febrifuge in human and veterinary medicine
BG60253B1 (bg) Човешки тъканен плазминогенен активатор
IT8419266A1 (it) Dispositivo per generare calore in tessuti" del corpo umano e procedimento di cenerazione di calore, particolarmente per la cura di tumori
EP0317568A4 (fr) Utilisation de stimulation de colonies de granulocytes-macrophage pour l'obtention d'un médicament pour le traitement de maladies bacteriènnes.
ZA90600B (en) Treatment of leukocyte dysefunction with gm-csf
GR3032224T3 (en) Therapeutic agent for threatened abortion.
KR870010871A (ko) 재조합 인체 알파 인터페론에 의한 기저세포 암종의 병소내적 치료방법
GR3000751T3 (en) Tpa-containing medical composition and use thereof
EP0397211A3 (fr) Administration percutanée de la 3'-azido-3'-déoxythymidine
KR900701311A (ko) 재조합 사람 α-인터페론을 병소내로 투여하여 편평세포 암을 치료하는 방법
IT1246050B (it) Impiego dell'eptastigmina nella terapia dell'ictus cerebrale.
粟坪华 et al. Observation on 38 cases of drug-induced myospasm treated with massage over the acupoints
周荣兴 et al. THE EFFECT OF ACUPUNCTURE ON THE PHAGOCYTIC ACTIVITY OF HUMAN LEUKOCYTES
Bantz et al. Ciprofloxacin treatment of deep respiratory tract infections.
Lowe et al. Subcutaneous ancrod therapy in peripheral arterial disease: improvement in blood viscosity and nutritional blood flow.
EP0282844A3 (en) Use of dopamine-agonists in the preparation of a medicament for the treatment of bone injuries
IL125789A (en) USE OF A DELETION VARIANT HUMAN t-PA PROTEIN IN THE PREPARATION OF A MEDICAMENT FOR TREATMENT OF VASCULAR DISEASES
HUT54302A (en) Process for producing medicaments comprising gamma-interferon, suitable for treating cancer of the ovary